Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomomi Fujii

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
International Journal of General Medicine|April 6, 2026
Factors Associated and Survival Outcomes Among Japanese Patients with Solid Cancer Who Developed Deep Vein Thrombosis (DVT)Yuya Masuda, Yoshihiro Yakushijin, Shintaro Yamanaka, et al.
European Journal of Haematology|July 20, 2007
Mortalin is a novel mediator of erythropoietin signalingRie Ohtsuka, Yasunobu Abe, Tomomi Fujii, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
International Journal of Molecular Sciences|August 23, 2016
MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2Tomomi Fujii, Keiji Shimada, Aya Asano, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 19, 2013
Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostateTomomi Fujii, Keiji Shimada, Osamu Asai, et al.
BMC Cancer|October 31, 2015
microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, et al.
European Journal of Case Reports in Internal Medicine|February 11, 2026
B-Cell Lymphoma Following an Indolent Course Over 30 Years with Immunophenotypic Changes at Each RecurrenceShintaro Yamanaka, Shinji Hasebe, Tomomi Fujii, et al.
Journal of Cutaneous Pathology|February 1, 2023
YAP1::MAML2 fusions in poromatosis: A report of two patientsYasuhiro Mitsui, Kohei Ogawa, Keisuke Goto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2002
[Acute lymphoblastic leukemia with p190 type bcr/abl chimeric mRNA at relapse]Ilseung Choi, Takamitsu Matsushima, Tomomi Fujii, et al.
International Journal of Clinical Oncology|October 24, 2020
The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphomaShintaro Yamanaka, Masao Miyagawa, Yoshifumi Sugawara, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
International Journal of General Medicine|April 6, 2026
Factors Associated and Survival Outcomes Among Japanese Patients with Solid Cancer Who Developed Deep Vein Thrombosis (DVT)Yuya Masuda, Yoshihiro Yakushijin, Shintaro Yamanaka, et al.
European Journal of Haematology|July 20, 2007
Mortalin is a novel mediator of erythropoietin signalingRie Ohtsuka, Yasunobu Abe, Tomomi Fujii, et al.
Prostate International|May 5, 2022
Prostate diseases and microbiome in the prostate, gut, and urineMakito Miyake, Yoshihiro Tatsumi, Kenta Ohnishi, et al.
International Journal of Molecular Sciences|August 23, 2016
MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2Tomomi Fujii, Keiji Shimada, Aya Asano, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 19, 2013
Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostateTomomi Fujii, Keiji Shimada, Osamu Asai, et al.
BMC Cancer|October 31, 2015
microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, et al.
European Journal of Case Reports in Internal Medicine|February 11, 2026
B-Cell Lymphoma Following an Indolent Course Over 30 Years with Immunophenotypic Changes at Each RecurrenceShintaro Yamanaka, Shinji Hasebe, Tomomi Fujii, et al.
Journal of Cutaneous Pathology|February 1, 2023
YAP1::MAML2 fusions in poromatosis: A report of two patientsYasuhiro Mitsui, Kohei Ogawa, Keisuke Goto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2002
[Acute lymphoblastic leukemia with p190 type bcr/abl chimeric mRNA at relapse]Ilseung Choi, Takamitsu Matsushima, Tomomi Fujii, et al.
International Journal of Clinical Oncology|October 24, 2020
The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphomaShintaro Yamanaka, Masao Miyagawa, Yoshifumi Sugawara, et al.
Pageof 16